IU Team Continuing Bone Study in Space

Posted: Updated:
The official mission patch for the group. (image courtesy of Indiana University) The official mission patch for the group. (image courtesy of Indiana University)

A team of researchers from the Indiana University School of Medicine in Indianapolis will Tuesday begin the second phase of an experiment heading to space. The research project will study the effect of spaceflight on osteoblast cells, which are essential to bone development, as well as the effects of certain drugs on bone healing. Melissa Kacena, director of basic and translational research at the school, is leading the effort in collaboration with NASA and the U.S. Army.

The first phase of the project took place in 2017, when the team sent mice into space and tested them using bone-healing therapies in weightlessness. In an interview with Inside INdiana Business Reporter Mary-Rachel Redman, Kacena said the effort is able to continue due to the success of the first phase.

"Most of the time I would've said it's a once-in-a-lifetime opportunity so clearly, for myself and one of my students, its a twice-in-a-lifetime opportunity," said Kacena. "I think that NASA and the peer review system have validated it and the Army came to us and approached us and so they thought that the work we do here in Indiana is really world renowned, that we're doing some of the best bone healing work and that we're the right people to tackle the problem and help them out."

The cells are set to launch into space July 21, heading for the International Space Station. There, astronauts will culture the cells to help researchers see the effects of an FDA-approved bone-healing drug, as well as a new drug identified by Kacena. The university says sending the cells into space ensures the drugs can be tested without any of the natural healing that weight-bearing can have on broken bones and damaged cells. 

"When we walk, we load our bones and this is really important in both keeping your bone mass and in the bone healing process. In spaceflight, you don't have that and therefore, we can really assess how well a drug will work in humans here on Earth because we get rid of that."

In the first phase of the project, the drug was tested on mice that had undergone an orthopaedic surgery. IU says testing osteoblast cells will give researchers a better understanding on how the drug will work on humans. Kacena says, if the drugs work in space, then they'll work anywhere.

You can read more about the first phase of the project from our Life Sciences INdiana e-newsletter by clicking here.

Kacena will monitor the experiment from the Kennedy Space Center and also ensure that ground control samples are treated as identically as possible to the spaceflight samples. When the cells return to Earth, they will be fully analyzed. 

The team of researchers includes undergraduate students, medical students and post-doctoral researchers. Kacena says the ultimate goal is to gain FDA approval and begin treating patients with the bone-healing therapy, but those results could still be 15-20 years away. 

  • Perspectives

    • Take Time to Face Reality

      When is the last time that you as a business owner truly stopped for 30 minutes or an hour and truly took some quiet time to reflect on your business? Like most owners, it’s probably been quite some time. We all get busy doing things, working hard, taking care of customers, running the business. But if we don’t take some time each day, week, month or quarter to slow down, we are setting ourselves up for failure. Business leaders and owners need the time to slow down to...



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • (Image provided by the Capital Improvement Board.)

      Indy Alters Plans for Downtown Hotels

      The city of Indianapolis has announced plans to change the framework for a major project in downtown Indy that has sparked controversy. The $120 million project, announced in October 2018, calls for an expansion of the Indiana Convention Center and two new hotels at Pan Am Plaza, which would add about 1,400 rooms. The project has drawn criticism from a group of hoteliers, who have expressed concern of a potential oversaturation in downtown Indy. Indianapolis Mayor Joe Hogsett issued...

    • (photo courtesy Butler University)

      'Banner Year' for Butler Fundraising

      Butler University is celebrating what it calls a ‘banner year’ for its fundraising efforts. As Fiscal Year 2019 ended, the university had received $41.4 million from 15,823 donors. Butler says it was the second-highest fundraising total over the past decade. “This level of generosity demonstrates the incredible loyalty of our alumni, faculty, staff, and community, and the commitment we share to advancing Butler’s mission of providing the highest quality liberal...

    • Shelly Timmons

      IU Health Names New Leader of Neurosurgery

      The Indiana University School of Medicine and IU Health Physicians have named Shelly Timmons to lead the department of neurosurgery. She previously served at Penn State Health Milton S. Hershey Medical Center as vice chair for administration in the department of neurosurgery and director of neurotrauma.  

    • (Photo Courtesy: Roche Diagnostics)

      Roche VP on List of Influential Women Executives

      An executive with Roche Diagnostics has joined an exclusive list of prominent and influential women, including Oprah Winfrey and Serena Williams.  Cindy Carlisle, Vice President of Human Resources at Roche Indy, was named to Savoy Magazine’s 2019 Most Influential Women in Corporate America. 

    • Bank of America Merrill Lynch Adds Mar

      Bank of America Merrill Lynch has named Lucia Mar as senior vice president and the newly created position of Indiana market executive for Global Commercial Banking. She most recently served as market manager for the Greater Tennessee market in business banking. Prior to becoming a market manager, Mar was a senior relationship manager with the healthcare and institutions team.